1

                                  UNITED STATES
                        SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934


      Date of report (Date of earliest event reported): May 4, 2006



                              Eastman Kodak Company
               (Exact name of registrant as specified in its charter)



New Jersey                            1-87                 16-0417150
- ----------------------------------------------------------------------
(State or Other Jurisdiction       (Commission           (IRS Employer
    of Incorporation)             File Number)      Identification No.)


                                343 State Street,
                            Rochester, New York 14650
            (Address of Principal Executive Office) (Zip Code)


      Registrant's telephone number, including area code (585) 724-4000
                                                          -------------


Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:

[  ]  Written communications pursuant to Rule 425 under the Securities
      Act (17 CFR 230.425)

[  ]  Soliciting material pursuant to Rule 14a-12 under the Securities
      Act (17 CFR 240.14a-12)

[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under
      the Exchange Act (17 CFR 240.14d-2(b))

[  ]  Pre-commencement communications pursuant to Rule 13e-4(c)under the
      Exchange Act (17 CFR 240.13e-4(c))

                                                                
 2

ITEM 8.01  Other Events

On May 4, 2006, Eastman Kodak Company announced that it is exploring
strategic alternatives for its Health Group.  Kodak's Health Group, with
2005 revenue of $2.7 billion, is a worldwide leader in health imaging,
including digital x-ray capture, medical printers, and x-ray film.

To assist in this effort, the Company has retained Goldman, Sachs & Co.
as its adviser.

A copy of the May 4, 2006 press release related to this announcement is
attached as Exhibit (99.1).


ITEM 9.01 Financial Statements and Exhibits

 (c)   Exhibit

 (99.1) Eastman Kodak Company press release dated May 4, 2006 regarding
        the announcement concerning the Health Group.


                                                               
 3


                                 SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.



                                          EASTMAN KODAK COMPANY



                                          By: /s/ Richard G. Brown,Jr.
                                          ----------------------------
                                             Richard G. Brown, Jr.
                                             Controller

Date:  May 4, 2006
                                                                 
 4

                           EASTMAN KODAK COMPANY
                             INDEX TO EXHIBITS

Exhibit No.

(99.1)  Eastman Kodak Company press release dated May 4, 2006 regarding
        the announcement concerning the Health Group.

                                                   Exhibit (99.1)

EASTMAN KODAK COMPANY

Media Contacts:
David Lanzillo 585-781-5481   david.lanzillo@kodak.com
David Kassnoff 585-724-2137   david.kassnoff@kodak.com

Kodak to Explore Strategic Alternatives for Health Business


ROCHESTER, N.Y., May 4 - Eastman Kodak Company announced that it

is exploring strategic alternatives for its Health Group.

  Kodak's Health Group, with 2005 revenue of $2.7 billion, is a

worldwide leader in health imaging, including digital x-ray

capture, medical printers, and x-ray film.

  "Kodak has a history of innovation in this industry, through

which we have built a business with significant market presence

and intellectual property assets," said Antonio M. Perez, Kodak's

Chairman and Chief Executive Officer. "We have proven products

and technology, a well-known and respected brand, worldwide

distribution, a large, satisfied and loyal customer base, and

employees with unrivaled experience in health imaging.

  "Our stated corporate goal is to be among the top three in

each of the businesses in which we compete," Perez said. "While

the Health Group is enjoying strong organic growth in elements of

its digital portfolio, such as digital capture solutions and

healthcare information solutions, we have been observing for some

time consolidation in this industry. Given our valuable assets

and the changing market landscape, we feel that now is the time

to investigate strategic alternatives."

  To assist in this effort, Kodak has retained Goldman, Sachs &

Co. as its adviser.


Antonio M. Perez, Kodak's Chairman and Chief Executive Officer,
and Robert Brust, Kodak's Chief Financial Officer, will host a
conference call today at 11:00 AM Eastern Time. Please use the
direct dial-in number 913-981-5591, access code 9167403. There is
no need to pre-register.

The call will be recorded and available for playback by 2:00 PM
Eastern time on May 4 by dialing 719-457-0820, access code
9167403. The playback number will be active until Thursday, May
11, 5:00 PM Eastern time.

 2

For those wishing to participate via an Internet Broadcast,
please access our Kodak.com Investor Relations web page at:
http://www.kodak.com/go/invest.

The conference call audio will be archived and available for
replay on this site approximately 1 hour following the live
broadcast.
                                #
2006